Wedbush Maintains Outperform on Imax, Raises Price Target to $54

Benzinga Newsdesk www.benzinga.com Positive 87.7%

Neg 0% Neu 0% Pos 87.7%

Wedbush analyst Alicia Reese maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $46 to $54.

Comments

No comments yet. Be the first!